Drug Trial Radar · NCT00736866
The Acetylcysteine for Contrast-Induced Nephropathy Trial
Last checked: Nov 20, 2026Latest source record: Jul 12, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,300
Planned (sponsor's estimate)
Start
Aug 2008
Primary completion
Jul 2010
Study completion Jul 2010
Sponsor
- Lead sponsor
- Hospital do CoracaoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Medley Pharmaceutical Industry SA
- First posted
- Aug 18, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy of acetylcysteine compared to placebo for the contrast-induced nephropathy prevention, between 48 and 96 hours after procedures that use contrast. Contrast-induced nephropathy is defined as an increase of 25% in serum creatinine before the procedure.
Conditions
- Acute Kidney Failure
Interventions
AcetylcysteineDrug
Acetylcysteine: 1200 mg every 12 hours for a total of 4 doses. Treatment is to be started 12 hours before angiography, that is, two doses should be administered before it. When this is not achievable, at least one dose should be administered before angiography.
PlaceboDrug
Placebo of Acetylcysteine: every 12 hours PO, for a total of 4 doses. Treatment is to be started 12 hours before angiography, that is, two doses should be administered before it. When this is not achievable, at least one dose should be administered before angiography.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Contrast-induced nephropathy incidenceTime frame: between 48 and 96 hours after angiographic procedures
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hospital do Coração
São Paulo, São Paulo, Brazil
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.